Retrospective, Evaluator-Blinded, Pilot and Pivotal Clinical Trials: Assessing the mirCaP Kit (hsv2-miR-H9/has-miR-3659) as a Diagnostic Marker for Prostate Cancer in Patients with PSA Gray Zone Levels
crossref（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要